4月16日,兆科眼科(06622)发布公告,宣布与Interpharma Public Company Limited签订三份分销及供应协议,以在泰国商业化NVK002、BRIMOCHOLPF及六款青光眼药物。根据协议,兆科眼科将授予Interpharma在泰国的独家进口、分销、推广、营销及销售权利,并将代表公司取得相关的当地药物注册。该等协议将使公司获得不可退还、不可抵扣的预付款项,以及根据若干...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.